| Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury K Kashani, A Al-Khafaji, T Ardiles, A Artigas, SM Bagshaw, M Bell, ... Critical care 17, 1-12, 2013 | 1292 | 2013 |
| COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup MK Nadim, LG Forni, RL Mehta, MJ Connor Jr, KD Liu, M Ostermann, ... Nature reviews nephrology 16 (12), 747-764, 2020 | 725 | 2020 |
| Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology RR Reichard, KB Kashani, NA Boire, E Constantopoulos, Y Guo, ... Acta neuropathologica 140, 1-6, 2020 | 550 | 2020 |
| Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 181 (1), 41-51, 2021 | 513 | 2021 |
| Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement M Ostermann, A Zarbock, S Goldstein, K Kashani, E Macedo, R Murugan, ... JAMA network open 3 (10), e2019209-e2019209, 2020 | 436 | 2020 |
| Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference M Ostermann, R Bellomo, EA Burdmann, K Doi, ZH Endre, SL Goldstein, ... Kidney international 98 (2), 294-309, 2020 | 323 | 2020 |
| Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption K Kashani, W Cheungpasitporn, C Ronco Clinical Chemistry and Laboratory Medicine (CCLM) 55 (8), 1074-1089, 2017 | 312 | 2017 |
| Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers EAJ Hoste, PA McCullough, K Kashani, LS Chawla, M Joannidis, ... Nephrology dialysis transplantation 29 (11), 2054-2061, 2014 | 268 | 2014 |
| Cardiac and vascular surgery–associated acute kidney injury: the 20th international consensus conference of the ADQI (acute disease quality initiative) group MK Nadim, LG Forni, A Bihorac, C Hobson, JL Koyner, A Shaw, ... Journal of the American Heart Association 7 (11), e008834, 2018 | 266 | 2018 |
| Creatinine: from physiology to clinical application K Kashani, MH Rosner, M Ostermann European journal of internal medicine 72, 9-14, 2020 | 253 | 2020 |
| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 247 | 2021 |
| Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup M Joannidis, LG Forni, SJ Klein, PM Honore, K Kashani, M Ostermann, ... Intensive care medicine 46, 654-672, 2020 | 241 | 2020 |
| Predictors of acute kidney injury in septic shock patients: an observational cohort study M Plataki, K Kashani, J Cabello-Garza, F Maldonado, R Kashyap, DJ Kor, ... Clinical Journal of the American Society of Nephrology 6 (7), 1744-1751, 2011 | 226 | 2011 |
| Tissue inhibitor metalloproteinase-2 (TIMP-2)⋅ IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI JL Koyner, AD Shaw, LS Chawla, EAJ Hoste, A Bihorac, K Kashani, ... Journal of the American Society of Nephrology 26 (7), 1747-1754, 2015 | 221 | 2015 |
| Culture-negative severe sepsis: nationwide trends and outcomes S Gupta, A Sakhuja, G Kumar, E McGrath, RS Nanchal, KB Kashani Chest 150 (6), 1251-1259, 2016 | 213 | 2016 |
| Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index KB Kashani, EN Frazee, L Kukrálová, K Sarvottam, V Herasevich, ... Critical care medicine 45 (1), e23-e29, 2017 | 210 | 2017 |
| Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients C Thongprayoon, W Cheungpasitporn, K Kashani Journal of thoracic disease 8 (5), E305, 2016 | 205 | 2016 |
| Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II JA Tumlin, R Murugan, AM Deane, M Ostermann, LW Busse, KR Ham, ... Critical care medicine 46 (6), 949-957, 2018 | 203 | 2018 |
| Management of refractory vasodilatory shock JC Jentzer, S Vallabhajosyula, AK Khanna, LS Chawla, LW Busse, ... Chest 154 (2), 416-426, 2018 | 199 | 2018 |
| A risk prediction score for acute kidney injury in the intensive care unit R Malhotra, KB Kashani, E Macedo, J Kim, J Bouchard, S Wynn, G Li, ... Nephrology Dialysis Transplantation 32 (5), 814-822, 2017 | 191 | 2017 |
